Skip to main content
OpenTrials

Clinical trial condition

Colorectal Neoplasms

Explore clinical trials studying Colorectal Neoplasms. Study availability and eligibility vary by location and protocol.

427 public trials 67 recruiting studies
Refine in advanced search Browse all conditions

Colorectal Neoplasms trial results

Active, Not Recruiting

Platform Study of JDQ443 in Combinations in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation

NCT05358249

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +25 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • NYU School of Medicine New York, United States
  • Novartis Investigative Site Leuven, Belgium
View all 13 locations
View Trial Details
Active, Not Recruiting

First in Human Study of AZD9592 in Solid Tumors

NCT05647122

Conditions
Advanced Solid Tumours, Bronchial Neoplasms, Carcinoma Non-small Cell Lung, +19 more
Locations
  • Research Site Duarte, California, United States
  • Research Site North Haven, Connecticut, United States
  • Research Site Washington D.C., District of Columbia, United States
  • Research Site Chicago, Illinois, United States
View all 46 locations
View Trial Details
Active, Not Recruiting

Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)

NCT04956640

Conditions
Adnexal Diseases, Biliary Tract Diseases, Biliary Tract Neoplasms, +36 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • USC Norris Cancer Hospital Los Angeles, California, United States
  • Chao Family Comprehensive Cancer Ctr. Orange, California, United States
  • Yale-New Haven Hospital New Haven, Connecticut, United States
View all 49 locations
View Trial Details
Active, Not Recruiting

Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Chinese Participants With Stage IV Colorectal Cancer (MK-3475-C66)

NCT05239741

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations
  • Beijing Cancer hospital-Digestive Oncology ( Site 0001) Beijing, Beijing Municipality, China
  • Beijing Peking Union Medical College Hospital-Medical Oncology ( Site 0011) Beijing, Beijing Municipality, China
  • Tianjin Medical University Cancer Institute and Hospital-Gastric oncology ( Site 0019) Tianjin, Beijing Municipality, China
  • The First Affiliated Hospital of Chongqing Medical University ( Site 0051) Chongqing, Chongqing Municipality, China
View all 32 locations
View Trial Details
Active, Not Recruiting

Combination Immunotherapy in Colorectal Cancer

NCT05571293

Conditions
Colonic Diseases, Colorectal Neoplasms, Diabetes Mellitus, Insulin-Dependent, 12, +9 more
Locations
  • Weill Cornell Medicine/New York-Presbyterian Brooklyn Methodist Hospital Brooklyn, New York, United States
  • Weill Cornell Medicine/NewYork Presbyterian - Queens Flushing, New York, United States
  • Weill Cornell Medicine/NewYork-Presbyterian Hospital New York, United States
View Trial Details
Active, Not Recruiting

ctDNA-guided Surveillance for Stage III CRC, a Randomized Intervention Trial

NCT04084249

Conditions
Colo-rectal Cancer, Colonic Cancer, Colonic Diseases, +19 more
Locations
  • Herlev Hospital Herlev, Capital Region of Denmark, Denmark
  • Gødstrup Hospital Herning, Central Jutland, Denmark
  • Regional Hospital Horsens Horsens, Central Jutland, Denmark
  • Regional Hospital Randers Randers, Central Jutland, Denmark
View Trial Details
Active, Not Recruiting

S0820, Adenoma and Second Primary Prevention Trial

NCT01349881

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +8 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 990 locations
View Trial Details
Active, Not Recruiting

A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid Tumor

NCT04008797

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +25 more
Locations
  • UAMS Little Rock, Arkansas, United States
  • University of California San Diego (UCSD) - Moores Cancer Center(All) La Jolla, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Pasadena Liver Center Pasadena, California, United States
View all 106 locations
View Trial Details

Related conditions